JAMA Surg4 Sep 2026
In a systematic review of 85 trials, incisional negative pressure wound therapy (INPWT) significantly lowered the risk of overall surgical site infections (SSIs) and related wound complications compared to standard dressings.
Ann Surg Oncol4 Sep 2026
Rural residency correlates with lower treatment rates and worse outcomes for colorectal liver metastases (CRLM).
Ann Surg Oncol4 Sep 2026
Detecting circulating tumor DNA (ctDNA) in patients with localized pancreatic ductal adenocarcinoma (PDAC) can help predict outcomes and guide surgical decision-making.
Ann Surg Oncol4 Sep 2026
Microscopically positive margins (R1) after colorectal liver metastasis resection indicate worse outcomes but require context for interpretation regarding recurrence and repeat surgeries.
Clin Gastroenterol Hepatol4 Sep 2026
A study found that fibrosis scores significantly differ among pancreatic surgery patients with and without chronic pancreatitis (CP), suggesting that reliance on fibrosis for diagnosis may lead to overdiagnosis of CP.
JAMA Surg3 Sep 2026
Adding radiotherapy to neoadjuvant chemotherapy for resectable pancreatic ductal adenocarcinoma improved pathologic response rates but failed to enhance overall or event-free survival.
JAMA Surg3 Sep 2026
The si-449 chondroitin sulfate adhesion barrier significantly decreases postoperative adhesion rates in open rectal resection patients, offering a promising option for improving surgical outcomes.
JAMA Surg3 Sep 2026
A deep learning model demonstrates strong potential for detecting surgical site infections (SSIs) from wound photographs, which could enhance postoperative monitoring and early diagnosis.
Ann Surg Oncol3 Sep 2026
Definitive chemoradiotherapy (DCRT) yields poor overall and progression-free survival for patients with adenocarcinoma of the esophagus or esophago-gastric junction, underscoring the need for careful patient selection and treatment strategy refinement.
Ann Surg Oncol3 Sep 2026
A new set of dual nomograms can effectively predict overall survival and recurrence risk following pancreatic resection for ductal adenocarcinoma, aiding surgical decision-making and postoperative management.